When a research team in China evaluated the efficacy and safety of using mesenchymal stem cells expanded from the bone marrow of non-self-donors to treat patients experiencing poor graft function after receiving transplants of non-self-donated blood stem cells , they found that the mesenchymal stem cells were both safe and effective for treating ... (more)
http://www.medilexicon.com/medicalnews.php?newsid=257842
http://www.medilexicon.com/medicalnews.php?newsid=257842
No comments:
Post a Comment